Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
177M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
21.6M
-
Shares change
-
-221K
-
Total reported value, excl. options
-
$149M
-
Value change
-
-$1.51M
-
Put/Call ratio
-
0.57
-
Number of buys
-
35
-
Number of sells
-
-24
-
Price
-
$6.88
Significant Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q3 2018
85 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share as of Q3 2018.
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.6M shares
of 177M outstanding shares and own 12.23% of the company stock.
Largest 10 shareholders include SUMMER ROAD LLC (3.03M shares), JENNISON ASSOCIATES LLC (2.34M shares), FMR LLC (2.3M shares), BlackRock Inc. (2.29M shares), Versant Venture Management, LLC (2.22M shares), WELLINGTON MANAGEMENT GROUP LLP (1.47M shares), Vanguard Group Inc (1.43M shares), Opaleye Management Inc. (800K shares), SV Health Investors, LLC (723K shares), and DELTEC ASSET MANAGEMENT LLC (620K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.